Pharrmaleaders, Asia’s biggest title in healthcare communications is gearing up to choose the top pharmaceutical & biotech companies for their dramatic & significant accomplishments in their respective field at the 5th Annual Pharmaceutical Leadership Awards 2012 in as many as 33 categories, the biggest & coveted title that India is anxiously looking at is the category that has made investors & stakeholder happy in the stock market. The pharma players like Aanjaneya Lifecare, Divi's Labs, TTK Healthcare and Ajanta Pharma have been nominated for BSE Award for the Best Return to Investors 2012.

The Award for the Best Return to Investors will be presented once the results for the Nomination process will end & the final vote count on 21st September. The winner will be presented an Award Trophy & a Certificate of Excellence.

Organized in association with BSE, Pharmexcil, IBEF & Ministry of Industry & Commerce, Government of India, the coveted & prestigious title BSE Award for the Best Return to Investors 2012 will be presented by K Shankaranarayan, his excellency, Governor of Maharashtra on Friday 21st September  amidst the presence of the veterans & who’s who’s of the Asia’s top healthcare leaders, pharma academia, ministers, policy makers, social entrepreneurs & medical practitioners.

More than top 200 professionals of the Industry are expected to attend the much awaited leadership event with the representation of overseas companies.

Speaking on the award nomination, Satya Brahma, chairman of the Juries & editor-in-chief of Pharmaleaders, said “This category has attracted tremendous attention in the stock market, pharma companies & in the general public as corporate ethics, corporate sustainability model are the norms of the day & with so much of scrutiny by the regulators, BSE Award for the best return to the investors will be a tight contest”.

Pharmaceutical Business Leadership Award Nominations 2012 has been carefully selected in 33 categories with several new entrants making it to the top category & big league as a result of their rising market presence. While the traditional award nominations have remained, some more categories have been created by the juries to give justice to the young companies & leaders, further a great emphasis has been given to some of the unsung heroes & their innovative growth stories.

Pharmaleaders has taken every possible steps to keep the award nominations credible & newsworthy. While more than 500 top houses have been honored with their names featuring in annual reports & international platforms, Pharmaceutical Leadership Business Leadership Awards are widely perceived to be most credible & independent & free from political interference. The three tier judging mechanism allows each nominee to undergo a public scrutiny first by the SMS, Email & than the eminent Juries will decide the fate of achievers tonight. In a significant development, Pharmaleaders has introduced a unique mechanism of creating mote than 5 Lakh sample size consisting of companies, pharmacy education, trade, investors & doctors.